DOSIMETRY OF I-123 IOMAZENIL IN HUMANS

被引:11
|
作者
VERHOEFF, NPLG
SOKOLE, EB
HENGST, D
STUBBS, JB
VANROYEN, EA
机构
[1] UNIV AMSTERDAM,ACAD MED CTR,DEPT RADIAT SAFETY,1105 AZ AMSTERDAM,NETHERLANDS
[2] OAK RIDGE INST SCI & EDUC,OAK RIDGE,TN
来源
EUROPEAN JOURNAL OF NUCLEAR MEDICINE | 1993年 / 20卷 / 07期
关键词
DOSIMETRY; I-123; RECEPTORS; BENZODIAZEPINE; FLUMAZENIL; IOMAZENIL;
D O I
10.1007/BF00176551
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
The distribution of the central benzodiazepine receptor specific ligand iodine-123 iomazenil was investigated in seven human adults from whole-body scans, blood samples and urine collected up to 24 h after injection. Using 12 source organs, the MIRD method was applied to calculate the absorbed radiation dose of the radioligand in various organs. The urinary bladder wall (0.15 mGy/MBq), lower large intestinal wall (0.071 mGy/MBq) testes (0.044 mGy/MBq) and upper large intestined wall (0.038 mGy/MBq) received the highest absorbed doses. The average effective dose equivalent of I-123-IBZM for adults was estimated to be 0.033 mSv/MBq.
引用
收藏
页码:580 / 584
页数:5
相关论文
共 50 条
  • [1] SPECT IMAGING OF THE BENZODIAZEPINE RECEPTOR IN HUMANS USING [I-123] IOMAZENIL
    ABI-DARGHAM, A
    LARUELLE, M
    GANDELMAN, M
    ZOGHBI, S
    RANDALL, P
    SEIBYL, J
    BALDWIN, RM
    PONCE, YZ
    CHARNEY, DS
    HOFFER, PB
    INNIS, RB
    SCHIZOPHRENIA RESEARCH, 1994, 11 (02) : 170 - 170
  • [2] FORMATION OF [I-123] 1-IODOBUTANE IN LABELING [I-123] IOMAZENIL BY IODODESTANNYLATION
    ZEAPONCE, Y
    BALDWIN, RM
    ZOGHBI, SS
    INNIS, RB
    JOURNAL OF NUCLEAR MEDICINE, 1993, 34 (05) : P90 - P90
  • [3] DOSIMETRY OF I-123 EPIDERPRIDE
    VOTAW, JR
    KESSLER, RM
    ANSARI, MS
    MASON, NS
    SCHMIDT, D
    VOTAW, DB
    BELL, RL
    MINNICK, DK
    DEPAULIS, T
    MANNING, RM
    HOLBURN, G
    JOURNAL OF NUCLEAR MEDICINE, 1993, 34 (05) : P158 - P158
  • [4] I-123 iomazenil SPECT in patients with mental disorders
    Nakabeppu Y.
    Nakajo M.
    Naruo T.
    Obo Y.
    Nozoe S.
    Takigawa M.
    Tsuchimochi S.
    Tani A.
    Tanaka H.
    Annals of Nuclear Medicine, 1997, 11 (4) : 339 - 344
  • [5] DOSIMETRY OF I-123 FOR NEWBORN AND INFANT
    GUILHEM, MT
    THERAIN, F
    JOURNAL DE BIOPHYSIQUE ET DE BIOMECANIQUE, 1987, 11 (02): : 63 - 68
  • [6] Prediction of improvement of cerebral perfusion with I-123 iomazenil SPECT
    Tatsuro Tsuchida
    Yoshiharu Yonekura
    Norihiro Sadato
    Norio Takahashi
    Kazutaka Yamamoto
    Yasushi Ishii
    Annals of Nuclear Medicine, 1999, 13 : 265 - 268
  • [7] Prediction of improvement of cerebral perfusion with I-123 iomazenil SPECT
    Tsuchida, T
    Yonekura, Y
    Sadato, N
    Takahashi, N
    Yamamoto, K
    Ishii, Y
    ANNALS OF NUCLEAR MEDICINE, 1999, 13 (04) : 265 - 268
  • [8] FORMATION OF 1-[I-123]IODOBUTANE IN LABELING [I-123] IOMAZENIL BY IODODESTANNYLATION - IMPLICATIONS FOR THE REACTION-MECHANISM
    ZEAPONCE, Y
    BALDWIN, RM
    ZOGHBI, SS
    INNIS, RB
    APPLIED RADIATION AND ISOTOPES, 1994, 45 (01) : 63 - 68
  • [9] Clinical values of I-123 iomazenil SPECT in patients with ischemic cerebrovascular disease: Comparison with I-123 IMP SPECT.
    Moriwaki, H
    Hashikawa, K
    Oku, N
    Ishida, M
    Seike, Y
    Fukuchi, K
    Watanabe, Y
    Matsumoto, M
    Nishimura, T
    JOURNAL OF NUCLEAR MEDICINE, 1996, 37 (05) : 39 - 39
  • [10] Reproducibility of [I-123]iomazenil equilibrium measurement of benzodiazepine receptors.
    Fujita, M
    Verhoeff, NP
    Baldwin, RM
    Zoghbi, SS
    Rajeevan, N
    Seibyl, JP
    Innis, RB
    JOURNAL OF NUCLEAR MEDICINE, 1998, 39 (05) : 208P - 208P